Cargando…

Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation

Mitochondrial DNA (mtDNA) mutations have been identified in various human cancers, including thyroid cancer. However, the relationship between mtDNA and thyroid cancer remains unclear. Previous studies by others and us strongly suggested that mtDNA mutations in complex I may participate in thyroid c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sixi, Bao, Xinzhu, Chen, Hongzhi, Jia, Manli, Li, Wen, Zhang, Luyi, Fan, Runxiao, Fang, Hezhi, Jin, Liqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020963/ https://www.ncbi.nlm.nih.gov/pubmed/35464760 http://dx.doi.org/10.1155/2022/9982449

Ejemplares similares

Variation of Cognitive Function During a Short Stay at Hypobaric Hypoxia Chamber (Altitude: 3842 M)
por: De Bels, D., et al.
Publicado: (2019)

The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population
por: Veiskarami, Parisa, et al.
Publicado: (2021)

Enhanced tumorigenicity by mitochondrial DNA mild mutations
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2015)

Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2020)

Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer
por: Fang, Hezhi, et al.
Publicado: (2010)

Mitochondrial ROS production and subsequent ERK phosphorylation are necessary for temperature preconditioning of isolated ventricular myocytes
por: Bhagatte, Y, et al.
Publicado: (2012)

Mitochondrial ROS activates ERK/autophagy pathway as a protected mechanism against deoxypodophyllotoxin-induced apoptosis
por: Kim, Sang-Hun, et al.
Publicado: (2017)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway
por: Cheng, Jianghong, et al.
Publicado: (2021)

Surfactin-Induced Apoptosis Through ROS–ERS–Ca(2+)-ERK Pathways in HepG2 Cells
por: Wang, Chun-ling, et al.
Publicado: (2013)

Polyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways
por: Zhang, Chao, et al.
Publicado: (2016)

MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
por: Fukasawa, Kazuya, et al.
Publicado: (2023)

A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway
por: Xia, Yuchen, et al.
Publicado: (2021)

Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth
por: Zhou, Chao, et al.
Publicado: (2018)

Bilateral striatal necrosis due to homoplasmic mitochondrial 3697G>A mutation presents with incomplete penetrance and sex bias
por: Zhong, Shanshan, et al.
Publicado: (2019)

Biallelic Mutations in ACACA Cause a Disruption in Lipid Homeostasis That Is Associated With Global Developmental Delay, Microcephaly, and Dysmorphic Facial Features
por: Lou, Xiaoting, et al.
Publicado: (2021)

Mitochondrial genetics – new model uncovering roles in tumorigenicity and metastasis
por: Beadnell, Thomas C., et al.
Publicado: (2018)

Crosstalk between G-quadruplex and ROS
por: Wu, Songjiang, et al.
Publicado: (2023)

Deregulated expression of TANK in glioblastomas triggers pro-tumorigenic ERK1/2 and AKT signaling pathways
por: Stellzig, J, et al.
Publicado: (2013)

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
por: Xie, Zhi-Hui, et al.
Publicado: (2017)

Mitochondrial DNA Polymerase POLG1 Disease Mutations and Germline Variants Promote Tumorigenic Properties
por: Singh, Bhupendra, et al.
Publicado: (2015)

Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway
por: Ding, Yangfang, et al.
Publicado: (2020)

PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway
por: Chiu, Ching-Chi, et al.
Publicado: (2017)

The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer
por: Chen, Tao, et al.
Publicado: (2011)

Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2023)

HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity
por: Kuo, Ching-Ying, et al.
Publicado: (2016)

Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation
por: Liu, Xiaoning, et al.
Publicado: (2018)

Mitochondrial ROS1 Increases Mitochondrial Fission and Respiration in Oral Squamous Cancer Carcinoma
por: Chang, Yu-Jung, et al.
Publicado: (2020)

Systematic analysis of a mitochondrial disease‐causing ND6 mutation in mitochondrial deficiency
por: Chen, Deyu, et al.
Publicado: (2020)

Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma
por: Wan, Lixin, et al.
Publicado: (2021)

Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
por: Baev, Artyom Y., et al.
Publicado: (2022)

Lipoxin A(4) Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
por: Zong, Liang, et al.
Publicado: (2016)

Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
por: Ciccarelli, Carmela, et al.
Publicado: (2016)

Protocol for mitochondrial isolation and sub-cellular localization assay for mitochondrial proteins
por: Zhou, Danyi, et al.
Publicado: (2023)

Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
por: Ding, Yi, et al.
Publicado: (2021)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

CpG-Oligodeoxynucleotides Alleviate Tert-Butyl Hydroperoxide-Induced Macrophage Apoptosis by Regulating Mitochondrial Function and Suppressing ROS Production
por: Qu, Yibai, et al.
Publicado: (2020)

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
por: Su, Xi, et al.
Publicado: (2019)

Eleostearic acid induces RIP1-mediated atypical apoptosis in a kinase-independent manner via ERK phosphorylation, ROS generation and mitochondrial dysfunction
por: Obitsu, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d7jtadrsv93ik7af974hobojmp